The articles published in this special issue of Pharmacogenomics culminate from a multidisciplinary group of researchers, demonstrating that data integration and multidisciplinary collaboration can yield novel approaches for handling large, complex data sets and reveal new insight and relevance to a complex illness such as chronic fatigue syndrome (CFS). Data were generated from a 2-day clinical study of CFS and comprised clinical, genomic and genetic information. The data, including over 500 clinical and epidemiological measurements and 20,000 gene expression measurements, was shared with 20 investigators who were challenged with integrating the data to delineate the heterogeneity of the study population and identify biological correlates of CFS.Technorati Tags: chronic fatigue syndrome, genetics, pharmacogenomics
I'm Dr. Joshua Schwimmer, a nephrologist and internal medicine physician in New York City. • Kidney Notes was the first active nephrology blog. (Trivia: Kidney Notes is so old that the National Library of Medicine still uses it as an example of how to formally cite blogs.) • Professionally, you can find me at Kidney.nyc. • Kidney Notes is for educational purposes only, not medical advice. Consult qualified health care professionals. See disclaimer.
Sunday, April 23, 2006
The Genetics of Chronic Fatigue Syndrome
In Pharmacogenomics: